GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE69836 Query DataSets for GSE69836
Status Public on Aug 01, 2015
Title Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK-positive cell growth.
Organism Homo sapiens
Experiment type Methylation profiling by high throughput sequencing
Summary We used bisulfite conversion and Illumina sequencing to analyse miR-150 DNA methylation pattern lost in cells treated with decitabine, a demethylating agent, Crizotinib, an inhibitor of of ALK activity or siALK
Overall design Targeted bisulfite conversion and Illumina sequencing in two cell lines bearing the t(2;5)(p23;q35)
Contributor(s) Meggetto F, Hoareau-Aveilla C
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jun 12, 2015
Last update date May 15, 2019
Contact name Coralie Hoareau-Aveilla
Organization name INSERM
Department CRCT
Street address 2 avenue Hubert Curien
City toulouse
ZIP/Postal code 31037
Country France
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (6)
GSM1709828 KARPAS-299 DMSO
GSM1709829 KARPAS-299 Decitabine
GSM1709830 KARPAS-299 PBS
BioProject PRJNA286887
SRA SRP059443

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE69836_RAW.tar 100.0 Kb (http)(custom) TAR (of XLSX)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap